Medtronic plc (MDT) has announced statistically significant 12-month results from a large, multicenter trial (RCT) that it says further proves the superiority of DTM …
Medtronic announced restructuring plans to cut annual costs by $450 million – $475 million by fiscal 2023 as the medical device maker introduces …
The US House Oversight Committee intends to issue a subpoena to AbbVie after the drugmaker failed to provide sufficient documents related to an …
The U.S.
Medical device makers are facing challenging times as elective surgeries have either been cancelled or postponed with hospitals and healthcare facilities shifting their …
Truist Securities lifted the price target on Medtronic to $125 (20% upside potential) from $105 and maintained a Buy rating, following upbeat 1Q …
Medtronic shares rose almost 4% after the medical device maker beat quarterly revenue and profit estimates amid a gradual resumption of elective surgeries …
Medtronic Plc raised its quarterly cash dividend by 7% ahead of the release of the medical device maker’s fiscal first-quarter results on Tuesday. …
Medtronic Plc (MDT) announced it has entered into a tender offer to buy all of the outstanding stock of spine surgery tech-maker Medicrea …
Medtronic Plc (MDT) has announced that the Blackstone Group’s (BX) life sciences division will invest $337 million into the research and development of …
